bioRxiv · 10.1101/2022.10.06.511069
Is The Stalk of the SARS-CoV-2 Spike Protein Druggable?
Abstract
The SARS-CoV-2 virus spike protein (SP) is the vector of the virus infectivity. The high propensity to mutate in key regions responsible for the recognition of the human angiotensinconverting enzyme 2 (hACE2) or the antibodies produced by the immune system following infection or vaccination makes subunit 1 of the SP a difficult to target and, to date, efforts have not delivered any ACE2 binding inhibitor yet. The inherent flexibility of the stalk region, within subunit S2, is key to SARS-CoV-2 high infectivity because it facilitates the receptor binding domain encounter with ACE2. Thus, it could be a valuable therapeutic target. By employing a fragment-based strategy, we computationally studied the druggability of the conserved part of the SP stalk by means of an integrated approach that combines molecular docking with high-throughput molecular dynamics simulations. Our results suggest that the druggability of the stalk is challenging and provide the structural basis for such difficulty.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Pipito, L., Reynolds, C. A., Deganutti, G.. 2022-10-06. Is The Stalk of the SARS-CoV-2 Spike Protein Druggable?. https://doi.org/10.1101/2022.10.06.511069
Cite the original work for its findings. Save a collection to share your selection of sources.